Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Sun Pharma and Rockwell enter into licensing agreement for Triferic in India
Triferic is an innovative anaemia therapy for the patients who are undergoing haemodialysis and offers a unique treatment option
Roche aims to ‘underwhelm’ on SMA drug price to challenge rivals
Spinraza's list price is $750,000 in the first year, and $375,000 thereafter, while Novartis's gene therapy for the genetic muscle…
Sree Chitra develops Circumin fibrin wafer to target malignant cancer cells
The bio material wafer is targeted for implantation to the affected site after surgical removal of cancer tissue for killing any…
Will Budget 2020 be a salve or a sting for India Pharma Inc?
Will the sector get their shocks post-budget, via a revamped UCPMP, further pricing woes, etc?
Acasti Pharma’s krill oil-derived drug fails late-stage study
The Canada-based drug developer said CaPre failed to show a statistically significant reduction in blood triglycerides compared to…
Biogen to buy early-stage potential Alzheimer’s, Parkinson’s treatment from Pfizer
Under the deal, Pfizer will get $75 million upfront and will be eligible for $635 million in potential milestone payments
Switzerland’s Obseva eyes China re-start for fertility drug that failed trial
In November last year, ObsEva said it was scrapping a development programme for nolasiban to help women undergoing in-vitro…
AstraZeneca to discontinue Epanova trial, expects $100 mn writedown
The drug is already approved in the United States to reduce high levels of triglyceride in adult patients
Alembic gets USFDA nod for Vilazodone Hydrochloride tablets used to treat depression
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Viibryd tablets, 10 mg, 20 mg, and 40…
Granules India says ‘voluntarily’ recalling ranitidine tabs
The company is in the process of recall from channel partners and the exact quantities are being estimated